Multiplex Lateral Flow Assay for Differential Bacterial Viral Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current multiplex lateral flow assays are inadequate for detecting multiple analytes in a single sample, particularly when one analyte is present at high concentration and another at low concentration, due to cross-reactivity and the inability to accurately quantify analytes at significantly different concentrations without sample dilution, which renders low-concentration analytes undetectable.

Innovation Solution

A lateral flow assay design with separate capture zones for each analyte, using labeled antibodies that specifically bind to their respective analytes, allowing for simultaneous detection and quantification of analytes at different concentrations without dilution, by competing with immobilized capture agents and generating distinct optical signals.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If a multiplex lateral flow assay is used to detect multiple analytes in a single sample, then the detection capability for multiple analytes is improved, but cross-reactivity between antibodies and analytes occurs and measurement precision deteriorates

Engineering Contradiction:
Improvedetection capabilityVSAvoidmeasurement precision
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The assay is divided into separate capture zones on the test strip, with each zone dedicated to detecting a specific analyte. This spatial segmentation prevents cross-reactivity between antibodies and different analytes, as each antibody only interacts with its target analyte at its designated capture zone, thereby maintaining measurement precision while enabling multiplex detection

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different capture zones are designed with locally optimized properties, including specific antibody concentrations and capture agent densities tailored to each analyte's characteristics. This local optimization ensures that each analyte is detected with high precision according to its own requirements, while the overall system maintains versatility for detecting multiple analytes simultaneously

Inventive Principle:
Principle #3Local quality

2Measurement precision

If sample dilution is performed to detect high concentration analytes, then the detection of high concentration analytes is improved, but low concentration analytes become undetectable

Engineering Contradiction:
Improvedetection accuracyVSAvoidanalyte concentration
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The test strip is segmented into multiple capture zones, each optimized for detecting analytes at different concentration ranges. One capture zone is designed with high sensitivity for low concentration analytes, while another is optimized for high concentration analytes. This allows simultaneous detection of both high and low concentration analytes in the undiluted sample without cross-interference

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different capture zones utilize different antibody concentrations, affinity constants, and capture agent densities to create distinct detection parameters for each analyte. This parameter optimization enables each zone to accurately detect its target analyte across its specific concentration range, allowing the system to handle analytes with concentrations differing by several orders of magnitude

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If a single lateral flow assay is used to detect analytes at significantly different concentrations, then test simplicity is improved, but the ability to accurately quantify all analytes deteriorates

Engineering Contradiction:
Improvetest simplicityVSAvoidquantification accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The lateral flow assay is segmented into multiple independent capture zones, each capable of accurately quantifying its target analyte independently. This segmentation allows the simple single-test format to maintain quantification accuracy for all analytes, as each zone operates independently without being affected by the concentration of other analytes

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The single lateral flow assay device is designed with multi-functionality to detect and quantify multiple analytes simultaneously. Each capture zone functions as an independent detection unit, but all work together within a single test platform, providing both operational simplicity and accurate quantification for multiple analytes with different concentration ranges

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise detection and quantification of multiple analytes in a single sample, even when concentrations differ by several orders of magnitude, without the need for sample dilution, improving diagnostic accuracy and efficiency.

Implementation Method 1

a labeled antibody against an analyte of interest is deposited on a test strip... an antibody against the analyte binds the labeled antibody-analyte complex

Methodology Applied
Scientific EffectAntigen-antibody binding:

Implementation Method 2

the first analyte in the fluid sample and the first complex compete to bind to the first immobilized capture agent in the first capture zone

Methodology Applied
Scientific EffectCompetitive binding:

Implementation Method 3

detecting a first signal from the first complex bound to the first immobilized capture agent in the first capture zone and a second signal from the second complex

Methodology Applied
Scientific EffectOptical detection:

Data Source

PatentUS20200348298A1Multiplex lateral flow assay for differentiating bacterial infections from viral infections
Publication Date: 2020.11.05 BECTON DICKINSON & CO
  • US20200348298A1 patent drawing
  • US20200348298A1 patent drawing
  • US20200348298A1 patent drawing

AI summary

Lateral flow assay devices, systems, and methods described herein measure concentration of a plurality of analytes of interest in a sample, and can determine the precise concentration of the plurality of analytes of interest, where one or more analytes of interest are present in the sample at high concentration and where one or more analytes of interest are present at low concentration. Precise concentration of each of the plurality of analytes can be determined when a single sample is applied to a single lateral flow assay in a single application, including when a first analyte of interest is present in the single sample at one-millionth the concentration of a second analyte of interest in the single sample.